EIOPA Publishes Technical Specification for Small and Non-Complex Undertakings and Groups Criteria Under Solvency II

Why It Matters

The specification provides clear, uniform criteria that reduce regulatory uncertainty for small insurers while enabling supervisors to apply proportional oversight, strengthening market stability and competition.

Key Takeaways

• EIOPA releases technical specs for SNCU/SNCG eligibility under Solvency II
• Criteria must be met for two consecutive financial years
• Nine risk indicators now have standardized calculation methods
• Guidance distinguishes solo undertakings from group structures
• Consistent application aims to reduce regulatory burden for small insurers

Pulse Analysis

The Solvency II framework, introduced in 2016, has long been praised for raising capital standards across Europe’s insurance sector. Recent amendments, notably the 2025 Solvency II Amending Directive, embed the principle of proportionality, allowing smaller insurers to operate under a lighter regulatory load. However, the lack of clear, uniform criteria for identifying Small and Non‑Complex Undertakings (SNCUs) and their group counterparts (SNCGs) created uncertainty for both firms and supervisors. EIOPA’s April 7 report seeks to close that gap with a detailed technical specification.

The new specification outlines both quantitative thresholds—such as asset size, premium volume, and employee count—and qualitative factors drawn from Articles 29a and 213a of the amended directive. Importantly, it requires firms to satisfy these conditions for two consecutive fiscal years, ensuring stability before a reduced supervisory regime is applied. The guidance also introduces nine standardized risk indicators, providing a common methodology for calculating market, credit, underwriting, and operational risks among SNCUs and SNCGs. Solo entities receive tailored treatment, while groups must demonstrate consolidated compliance across subsidiaries.

For the market, the clarified rules promise faster onboarding of small insurers, lower compliance costs, and more predictable supervisory expectations. Regulators gain a transparent tool to verify proportionality, reducing the risk of regulatory arbitrage. Yet firms will need to adjust data collection and reporting processes to align with the nine risk indicators, potentially prompting investment in actuarial and IT capabilities. Overall, EIOPA’s technical specification marks a significant step toward a more balanced Solvency II regime, fostering competition while preserving policyholder protection.